Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Active Pharmaceutical Ingredients  TAJ PHARMACEUTICALS LIMITED
   
   PRODUCT LIST
   Home
   API
   Pharmaceuticals API List >>
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 




 


 

 

 













 

 

 

HOME >> Pharmaceuticals API List 4 >> Cefotetan Sodium


 

Cefotetan Sodium
pdf api
CAS NO: 74356-00-6

Cefotetan disodium is a semisynthetic, beta-lactamase resistant, cephalosporin (cephamycin) antibiotic.

In vitro studies indicate that the bactericidal action of cefotetan results from an interference of bacterial cell wall synthesis by inhibiting the cross-linking of peptidoglycan.

Dosage And Administration:


Treatment: Adults: The usual adult dosage is 1 or 2 g administered i.v. or i.m. every 12 hours for 5 to 10 days.

Proper dosage and route of administration should be determined by the condition of the patient, severity of the infection and susceptibility of the causative organism. Therapy may be started while awaiting the results of susceptibility testing.

The i.v. route is preferable for patients with bacteremia, bacterial septicemia or other severe or life-threatening infections or for patients who may be at risk particularly if shock is present or impending.

Availability And Storage: 1 g: Each vial of dry, white to pale yellow powder contains: cefotetan disodium equivalent to 1 g cefotetan activity for i.v. and i.m. administration. Nonmedicinal ingredients: sodium bicarbonate. Sodium: 3.4 mmol (78.7 mg). Vials of 10 mL.

2 g: Each vial of dry, white to pale yellow powder contains: cefotetan disodium equivalent to 2 g cefotetan activity for i.v. and i.m. administration. Nonmedicinal ingredients: sodium bicarbonate. Sodium: 6.8 mmol (157.4 mg). Vials of 20 mL.

Store below 25C and protect from light.

Drug Interactions:


Renal function should be carefully monitored, especially if high dosages of the aminoglycosides are to be administered or if therapy is prolonged, because of the potential nephrotoxicity and ototoxicity of aminoglycosidic antibiotics.

Although, to date, this has not been noted when cefotetan was given alone, increased nephrotoxicity has been reported following concomitant administration of cephalosporins and aminoglycoside antibiotics.

However, at the recommended dose, enhancement of nephrotoxicity is unlikely to be a problem with cefotetan.
 

Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  



Taj pharmaceuticals API Logo

Cefotetan Sodium

New Chemicals at Taj Pharmaceuticals Ltd.

Cefuroxime Sodium

Cefoxitin Sodium

Cefotetan Sodium

Cefotaxime Sodium

Cefoperazone Sodium

Ceftizoxime Sodium

Cefazolin Sodium

Cefalexin

Meropenem

Cefradine

Cefadroxil

Cefprozil

Cefixime

Ceftibuten

Cefditoren Pivoxil

Betalactams Piperacillin

Tazobactam

Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.